The National Health Surveillance Agency (Anvisa) reported that, on Monday, 28, a meeting was held with technicians from the agency and the Butantan Institute to discuss the Butanvac vaccine against covid-19. According to the agency, the clinical research protocol is already approved, but there is still a lack of specific data to start the tests in humans.
In a note, the regulatory body states that the purpose of the meeting was to evaluate the information already presented by Butantan. “But for the vaccine to start being applied to human beings, it is necessary to present specific data, which are still being generated by Butantan”, he says. According to Anvisa, an example of the missing data refers to the inactivation of the virus used in the vaccine.
Read Also
- Balearics coronavirus figures for Monday, September 6 Sep 6, 2021
- Lula and his wife tested positive for coronavirus Jun 6, 2022
- Covid, the study: similar pandemic risk may double in the coming decades Aug 31, 2021
- The receipt is ‘melted’ up to 23% of the income in Thermal Treatments Sep 6, 2021
- Back hidden, for middle and high school students Aug 10, 2020
- A study discovers the protective effect of moderate consumption of eggs in cardiovascular diseases May 29, 2022
- Concerns about skin cancer are on the rise: five tips to protect your child better Apr 20, 2021